000 02190cam  2200373zi 4500
0019.923787
003CaOODSP
00520230613150619
006m     o  d f      
007cr cn|||||||||
008230612e20071030onc     ob   f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aYM32-6/99-15E-PDF
1001 |aNorris, Sonya, |eauthor.
24510|aHepatitis C / |cSonya Norris.
250 |aRevised
264 1|a[Ottawa] : |bLibrary of Parliament, Parliamentary Information and Research Service = Bibliothèque du Parlement, Service d'information et de recherche parlementaires, |c30 October 2007.
300 |a1 online resource (14 pages).
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
4901 |a[Modular backgrounders] ; |vPRB 99-15E
500 |aCover title.
500 |aIssued also in French under title : L’hépatite C.
504 |aIncludes bibliographical references.
520 |a"In recent years, hepatitis C has become a familiar disease to most Canadians as a result of the much- publicized scandal about its transmission via blood transfusion or blood products. Although the disease itself is not new, the virus responsible for it has only recently been identified, and much work remains to gain a full understanding of how it affects the progression of the disease. This paper will review some of the major aspects of hepatitis C, including ongoing research aimed at developing an effective method of treatment, immunization and cure, and will summarize the issues surrounding compensation for Canadians who contracted hepatitis C through the blood supply"--Background, page [1].
650 0|aHepatitis C|xTreatment|zCanada.
650 0|aHepatitis C virus|zCanada.
7101 |aCanada. |bParliamentary Information and Research Service, |eissuing body.
77508|tL’hépatite C / |w(CaOODSP)9.923792
795 |tHepatitis C |b2005|w(CaOODSP)9.560308
830#0|a[Modular backgrounders]|vPRB 99-15E.|w(CaOODSP)9.504922
85640|qPDF|s132 KB|uhttps://publications.gc.ca/collections/collection_2023/bdp-lop/YM32-6-99-15-eng.pdf